• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Strides receives USFDA approval for Sevelamer Carbonate Tablets

    PRESS RELEASE

    Aurobindo`s Generic Sevelamer Hydrochloride Receives Approval in the U.S.

    FDA

    We are glad to share that the US DMF for Sevelamer Hydrochloride was successfully submitted to the USFDA. We have a distinctive advantage

    PRESS RELEASE

    Unicycive`s pivotal trial of Takeda kidney drug rival hits goal

    FIERCE PHARMA

    Lupin launches generic medication in US market

    ECONOMIC TIMES

    Lupin`s Generic Sevelamer Hydrochloride Receives Approval In US

    FDA

    Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets

    EXPRESSPHARMA

    Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021

    PRNEWSWIRE

    Glenmark Pharma gets USFDA nod for drug for patients on dialysis

    ECONOMIC TIMES

    Sanofi returns to growth with Dupixent and vaccines leading turnaround

    FIERCE PHARMA

    Ardelyx Presents Data Demonstrating Synergy between Tenapanor & Sevelamer

    PR NEWSWIRE

    Impax Labs shares rise on FDA approval of generic Renvela

    MARKETWATCH

    Cancer, hepatitis treatments set for boost as China overhauls drugs list

    REUTERS

    Sanofi adds its sales heft to Relypsa`s forthcoming patiromer launch

    FIERCE PHARMA MARKETING

    Genzyme`s Tasermity (Sevelamer Hydrochloride) Approved in Europe For Hyperphosphatemia

    EMA

    First Stem-Cell Therapy Recommended For Approval in EU

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.